The Genetic Engineering of Hematopoietic Stem Cells: the Rise of Lentiviral Vectors, the Conundrum of the LTR, and the Promise of Lineage-restricted Vectors
Open Access
- 1 March 2007
- journal article
- review article
- Published by Elsevier in Molecular Therapy
- Vol. 15 (3), 445-456
- https://doi.org/10.1038/sj.mt.6300060
Abstract
No abstract availableThis publication has 225 references indexed in Scilit:
- Gene transfer in humans using a conditionally replicating lentiviral vectorProceedings of the National Academy of Sciences, 2006
- Cytokines: Value-Added Products in Hematopoietic Stem Cell Gene TherapyMolecular Therapy, 2004
- Sustained transgene expression by human cord blood derived CD34+ cells transduced with simian immunodeficiency virus agmTYO1‐based vectors carrying the human coagulation factor VIII gene in NOD/SCID miceThe Journal of Gene Medicine, 2004
- Recombinant factor VIII expression in hematopoietic cells following lentiviral transductionGene Therapy, 2003
- Occurrence of leukaemia following gene therapy of X-linked SCIDNature Reviews Cancer, 2003
- Site-specific genomic integration produces therapeutic Factor IX levels in miceNature Biotechnology, 2002
- New genes involved in cancer identified by retroviral taggingNature Genetics, 2002
- Lentiviral Vectors for Enhanced Gene Expression in Human Hematopoietic CellsMolecular Therapy, 2000
- Locus control regions of mammalian β-globin gene clusters: combining phylogenetic analyses and experimental results to gain functional insightsGene, 1997
- HIV-1 infection of nondividing cells: C-terminal tyrosine phosphorylation of the viral matrix protein is a key regulatorCell, 1995